Office of Student Health

Rapid ANTIGEN Testing (Available ONLY to TAMIU Community)

• Walk-up opportunity; no appointment needed

• Scan posted QR code at the testing site on your smartphone
• You’ll be linked to an authentication page; enter your valid TAMIU NetID and password
• A DUO prompt and confirmation will follow
• A simple online form follows and you’ll provide your email, phone, and University ID.  Please make sure these are accurately entered
• Upon testing completion and results entry, an email will be sent to you with your results in approximately 30 minutes
• Rapid Antigen Testing is open to all TAMIU students, faculty, staff and retirees

For more information, please contact The Office of Community Relations and Special Events at 956.326.2001

Curative (available to TAMIU and public community)

• Appointment required (link below)

• Testing is self-collected using a shallow nasal swab

• Must bring valid picture ID for check-in

• Results available in 24 - 48 hours

• Testing kiosk located between Dr. F. M. Canseco Hall and Anthony J. and Georgia A. Pellegrino Hall

• Testing is available Monday - Thursday, 9 a.m. - 6 p.m. and Friday from 9 a.m. - 5 p.m.

Employees, you will need to present insurance card on-site or input online for first, but not subsequent testings.

Students: testing will be provided with or without insurance proof.

• No appointment required! Walk-up opportunity!
• MODERNA (18 years or older), JANSSEN (16 years or older) and PFIZER (12 years or older) 1st, 2nd, 3rd and booster doses available
• Booster doses are available: MODERNA (18 years or older) and PFIZER (12 years or older)
• Pediatric PFIZER doses are available for children ages 5-11 years old
• Mix and match doses are approved by the CDC
• SECOND BOOSTER (MODERNA and PFIZER) is now available for those who are eligible 
• If you received Pfizer or Moderna primary series plus a first booster at least 4 months ago, you may be eligible for a SECOND BOOSTER vaccine
• Guidance limits those eligible to receive a second booster dose to the following:
  • Individuals 50+ who have had a first booster of any authorized or approved COVID-19 vaccine at least 4 months ago
  • Individuals 18 years and older may receive a second booster of the MODERNA vaccine if they received a primary series of MODERNA and a first booster at least 4 months ago and are moderately or severely immunocompromised
  • Individuals 12 years and older may receive a second booster of the PFIZER vaccine if they received a primary series of PFIZER and a first boost at least 4 months ago and are moderately or serverely immunocompromised
•  In select individuals who are moderate to severely immunocompromised the CDC recommends a 3rd dose mRNA vaccine 28 days after their 2nd dose of a mRNA vaccine. They suggest using the same mRNA vaccine as previous but if unable to give the same vaccine as previous you can give the alternative mRNA vaccine
• Moderate to severe immunodeficiencies are classified by the CDC as the following: 
  • Been receiving active cancer treatment for tumors or cancers of the blood
  • Received an organ transplant and currently taking medicine to suppress the immune system
  • Received a stem cell transplant within the last 2 years or currently taking medicine to suppress the immune system
  • Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • Advanced or untreated HIV infection
  • Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response